Loading...

Sonic Healthcare

OTCPK:SKHC.F
Snowflake Description

Established dividend payer with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SKHC.F
OTCPK
A$13B
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Sonic Healthcare Limited, a healthcare company, provides medical diagnostic services, and administrative services and facilities to medical practitioners. The last earnings update was 155 days ago. More info.


Add to Portfolio Compare Print
SKHC.F Share Price and Events
7 Day Returns
0.7%
OTCPK:SKHC.F
-2.6%
US Healthcare
-0.9%
US Market
1 Year Returns
-3.4%
OTCPK:SKHC.F
0.3%
US Healthcare
3.8%
US Market
SKHC.F Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Sonic Healthcare (SKHC.F) 0.7% 1.1% 7.4% -3.4% 8.9% 11.8%
US Healthcare -2.6% 1.9% 9% 0.3% 23.2% 61.9%
US Market -0.9% 1.1% 1.1% 3.8% 35.5% 42.1%
1 Year Return vs Industry and Market
  • SKHC.F underperformed the Healthcare industry which returned 0.3% over the past year.
  • SKHC.F underperformed the Market in United States of America which returned 3.8% over the past year.
Price Volatility
SKHC.F
Industry
5yr Volatility vs Market

SKHC.F Value

 Is Sonic Healthcare undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Sonic Healthcare to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Sonic Healthcare.

OTCPK:SKHC.F Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 9 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.6%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:SKHC.F
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.63
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.626 (1 + (1- 30%) (20.98%))
0.811
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.81
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.811 * 5.96%)
7.56%

Discounted Cash Flow Calculation for OTCPK:SKHC.F using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Sonic Healthcare is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:SKHC.F DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (AUD, Millions) Source Present Value
Discounted (@ 7.56%)
2020 594.00 Analyst x1 552.23
2021 675.03 Est @ 13.64% 583.44
2022 745.02 Est @ 10.37% 598.66
2023 805.20 Est @ 8.08% 601.52
2024 857.32 Est @ 6.47% 595.42
2025 903.18 Est @ 5.35% 583.17
2026 944.40 Est @ 4.56% 566.91
2027 982.31 Est @ 4.01% 548.20
2028 1,017.95 Est @ 3.63% 528.15
2029 1,052.15 Est @ 3.36% 507.51
Present value of next 10 years cash flows A$5,665.20
OTCPK:SKHC.F DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= A$1,052.15 × (1 + 2.73%) ÷ (7.56% – 2.73%)
A$22,363.58
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= A$22,363.58 ÷ (1 + 7.56%)10
A$10,787.11
OTCPK:SKHC.F Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= A$5,665.20 + A$10,787.11
A$16,452.31
Equity Value per Share
(AUD)
= Total value / Shares Outstanding
= A$16,452.31 / 473.94
A$34.71
OTCPK:SKHC.F Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in OTCPK:SKHC.F represents 0.68786x of ASX:SHL
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.68786x
Value per Share
(Listing Adjusted, USD)
= Value per Share (AUD) x Listing Adjustment Factor
= A$ 34.71 x 0.68786
$23.88
Value per share (USD) From above. $23.88
Current discount Discount to share price of $18.93
= -1 x ($18.93 - $23.88) / $23.88
20.7%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Sonic Healthcare is available for.
Intrinsic value
21%
Share price is $18.93 vs Future cash flow value of $23.88
Current Discount Checks
For Sonic Healthcare to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Sonic Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Sonic Healthcare's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Sonic Healthcare's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Sonic Healthcare's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:SKHC.F PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in AUD A$1.10
ASX:SHL Share Price ** ASX (2019-07-23) in AUD A$27.52
United States of America Healthcare Industry PE Ratio Median Figure of 57 Publicly-Listed Healthcare Companies 21.91x
United States of America Market PE Ratio Median Figure of 3,083 Publicly-Listed Companies 17.8x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Sonic Healthcare.

OTCPK:SKHC.F PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:SHL Share Price ÷ EPS (both in AUD)

= 27.52 ÷ 1.10

24.93x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sonic Healthcare is overvalued based on earnings compared to the US Healthcare industry average.
  • Sonic Healthcare is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Sonic Healthcare's expected growth come at a high price?
Raw Data
OTCPK:SKHC.F PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 24.93x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts
9.1%per year
United States of America Healthcare Industry PEG Ratio Median Figure of 43 Publicly-Listed Healthcare Companies 1.74x
United States of America Market PEG Ratio Median Figure of 2,118 Publicly-Listed Companies 1.58x

*Line of best fit is calculated by linear regression .

OTCPK:SKHC.F PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 24.93x ÷ 9.1%

2.73x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sonic Healthcare is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Sonic Healthcare's assets?
Raw Data
OTCPK:SKHC.F PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in AUD A$10.71
ASX:SHL Share Price * ASX (2019-07-23) in AUD A$27.52
United States of America Healthcare Industry PB Ratio Median Figure of 95 Publicly-Listed Healthcare Companies 2.48x
United States of America Market PB Ratio Median Figure of 5,249 Publicly-Listed Companies 1.78x
OTCPK:SKHC.F PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:SHL Share Price ÷ Book Value per Share (both in AUD)

= 27.52 ÷ 10.71

2.57x

* Primary Listing of Sonic Healthcare.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Sonic Healthcare is overvalued based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Sonic Healthcare's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Sonic Healthcare has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SKHC.F Future Performance

 How is Sonic Healthcare expected to perform in the next 1 to 3 years based on estimates from 9 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Sonic Healthcare expected to grow at an attractive rate?
  • Sonic Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Sonic Healthcare's earnings growth is positive but not above the United States of America market average.
  • Sonic Healthcare's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
Raw Data
OTCPK:SKHC.F Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:SKHC.F Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts 9.1%
OTCPK:SKHC.F Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts 7.3%
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 14%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:SKHC.F Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:SKHC.F Future Estimates Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-06-30 7,059 940 622 7
2020-06-30 6,760 884 586 9
2019-06-30 6,164 806 529 9
OTCPK:SKHC.F Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2018-12-31 5,770 784 470
2018-09-30 5,655 776 473
2018-06-30 5,541 768 476
2018-03-31 5,430 762 468
2017-12-31 5,319 755 460
2017-09-30 5,220 746 444
2017-06-30 5,122 736 428
2017-03-31 5,081 726 444
2016-12-31 5,040 716 460
2016-09-30 5,029 712 456
2016-06-30 5,018 708 451
2016-03-31 4,829 647 406

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Sonic Healthcare's earnings are expected to grow by 9.1% yearly, however this is not considered high growth (20% yearly).
  • Sonic Healthcare's revenue is expected to grow by 7.3% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:SKHC.F Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below

All data from Sonic Healthcare Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SKHC.F Future Estimates Data
Date (Data in AUD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-06-30 1.33 1.42 1.26 6.00
2020-06-30 1.25 1.32 1.17 8.00
2019-06-30 1.19 1.23 1.13 8.00
OTCPK:SKHC.F Past Financials Data
Date (Data in AUD Millions) EPS *
2018-12-31 1.10
2018-09-30 1.12
2018-06-30 1.13
2018-03-31 1.11
2017-12-31 1.10
2017-09-30 1.06
2017-06-30 1.03
2017-03-31 1.07
2016-12-31 1.11
2016-09-30 1.10
2016-06-30 1.10
2016-03-31 1.00

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Sonic Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Sonic Healthcare's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Sonic Healthcare has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SKHC.F Past Performance

  How has Sonic Healthcare performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Sonic Healthcare's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Sonic Healthcare's year on year earnings growth rate has been positive over the past 5 years.
  • Sonic Healthcare's 1-year earnings growth is less than its 5-year average (2.3% vs 6.2%)
  • Sonic Healthcare's earnings growth has not exceeded the US Healthcare industry average in the past year (2.3% vs 2.7%).
Earnings and Revenue History
Sonic Healthcare's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Sonic Healthcare Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SKHC.F Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 5,769.60 470.04 489.06
2018-09-30 5,655.48 472.82 480.66
2018-06-30 5,541.37 475.61 472.26
2018-03-31 5,430.09 467.60 466.05
2017-12-31 5,318.80 459.60 459.84
2017-09-30 5,220.47 443.68 454.38
2017-06-30 5,122.14 427.77 448.93
2017-03-31 5,081.30 444.00 449.71
2016-12-31 5,040.46 460.22 450.49
2016-09-30 5,029.09 455.80 447.24
2016-06-30 5,017.72 451.37 444.00
2016-03-31 4,828.53 406.47 425.37
2015-12-31 4,639.34 361.56 406.74
2015-09-30 4,419.93 354.63 389.49
2015-06-30 4,200.53 347.70 372.24
2015-03-31 4,114.92 364.69 361.32
2014-12-31 4,029.31 381.69 350.39
2014-09-30 3,971.39 383.34 340.85
2014-06-30 3,913.48 384.98 331.32
2014-03-31 3,799.44 373.33 319.14
2013-12-31 3,685.41 361.68 306.97
2013-09-30 3,584.74 348.34 295.61
2013-06-30 3,484.07 335.00 284.25
2013-03-31 3,442.56 329.33 277.93
2012-12-31 3,401.04 323.67 271.62
2012-09-30 3,373.33 319.83 268.43

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Sonic Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Sonic Healthcare used its assets more efficiently than the US Healthcare industry average last year based on Return on Assets.
  • Sonic Healthcare has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Sonic Healthcare's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Sonic Healthcare has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SKHC.F Health

 How is Sonic Healthcare's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Sonic Healthcare's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Sonic Healthcare is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Sonic Healthcare's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Sonic Healthcare's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.6x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Sonic Healthcare Company Filings, last reported 6 months ago.

OTCPK:SKHC.F Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 5,001.35 2,736.60 660.91
2018-09-30 5,001.35 2,736.60 660.91
2018-06-30 4,282.93 2,795.16 313.27
2018-03-31 4,282.93 2,795.16 313.27
2017-12-31 4,049.36 2,843.27 328.68
2017-09-30 4,049.36 2,843.27 328.68
2017-06-30 3,926.13 2,870.07 437.62
2017-03-31 3,926.13 2,870.07 437.62
2016-12-31 3,779.69 2,719.48 324.42
2016-09-30 3,779.69 2,719.48 324.42
2016-06-30 3,732.71 2,569.80 290.44
2016-03-31 3,732.71 2,569.80 290.44
2015-12-31 3,607.56 2,735.12 256.43
2015-09-30 3,607.56 2,735.12 256.43
2015-06-30 3,326.00 2,224.24 249.39
2015-03-31 3,326.00 2,224.24 249.39
2014-12-31 3,215.57 2,159.62 191.67
2014-09-30 3,215.57 2,159.62 191.67
2014-06-30 3,108.99 1,970.51 232.14
2014-03-31 3,108.99 1,970.51 232.14
2013-12-31 3,075.94 2,158.21 229.32
2013-09-30 3,075.94 2,158.21 229.32
2013-06-30 2,918.10 1,959.13 219.73
2013-03-31 2,918.10 1,959.13 219.73
2012-12-31 2,695.08 1,731.42 182.94
2012-09-30 2,695.08 1,731.42 182.94
  • Sonic Healthcare's level of debt (54.7%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (70.1% vs 54.7% today).
  • Debt is well covered by operating cash flow (28.7%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 8.7x coverage).
X
Financial health checks
We assess Sonic Healthcare's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Sonic Healthcare has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SKHC.F Dividends

 What is Sonic Healthcare's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.98%
Current annual income from Sonic Healthcare dividends. Estimated to be 3.4% next year.
If you bought $2,000 of Sonic Healthcare shares you are expected to receive $60 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Sonic Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).
  • Sonic Healthcare's dividend is below the markets top 25% of dividend payers in United States of America (3.77%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:SKHC.F Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 21 Stocks 1.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2017 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:SKHC.F Future Dividends Estimate Data
Date (Data in A$) Dividend per Share (annual) Avg. No. Analysts
2021-06-30 0.96 8.00
2020-06-30 0.92 10.00
2019-06-30 0.84 10.00
OTCPK:SKHC.F Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2019-02-19 0.820 3.184
2018-08-15 0.810 3.456
2018-02-14 0.780 3.208
2017-08-15 0.770 3.456
2017-02-14 0.750 3.342
2016-09-22 0.740 3.447
2016-08-16 0.740 3.340
2016-02-16 0.710 3.519
2015-08-17 0.700 3.714
2014-09-22 0.670 3.470
2014-08-18 0.670 3.849
2013-09-25 0.620 3.660
2013-08-19 0.620 3.956
2013-02-18 0.600 4.301
2012-09-26 0.590 4.429
2012-08-20 0.590 4.477
2011-09-29 0.590 4.959
2011-08-22 0.590 5.215
2011-03-04 0.590 4.928
2010-08-24 0.590 5.191
2010-02-22 0.590 5.009
2009-08-28 0.570 3.996
2009-02-24 0.540 4.643
2008-08-21 0.520 3.862

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Sonic Healthcare's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (1.3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.4x coverage).
X
Income/ dividend checks
We assess Sonic Healthcare's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Sonic Healthcare afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Sonic Healthcare has a total score of 5/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SKHC.F Management

 What is the CEO of Sonic Healthcare's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Colin Goldschmidt
COMPENSATION A$5,087,789
AGE 65
CEO Bio

Dr. Colin Stephen Goldschmidt, M.B.B.Ch., F.R.C.P.A., F.A.I.C.D. serves as the Chief Executive Officer of Sonic Healthcare Limited since 1993 and has been its Managing Director since 1992. Dr. Goldschmidt served as Medical Director of Douglass Hanly Moir Pathology. He served as the Chief Executive Officer of Douglass Hanly Moir Pathology since 1993. He has been a Non-Executive Director at Independent Practitioner Network Pty Limited since August 1, 2005. He has been an Executive Director of Sonic Healthcare Limited since January 28, 1993. He serves as a Director at Sonic Healthcare USA, Inc. He served as a Director of SciGen Ltd. from 1999 to October 20, 2005. He served as a Non-Executive Director of Silex Systems Ltd. from 1992 to May 2, 2014. He has led Sonic’s global expansion by committing it to a model of Medical Leadership, which incorporates unique operational and cultural attributes. He has expertise in Healthcare industry and company management. He holds memberships with numerous industry, medical and laboratory associations. He is a qualified medical doctor who then undertook specialist pathology training in Sydney, before gaining his qualification as a specialist pathologist in 1986.

CEO Compensation
  • Colin's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Colin's remuneration is lower than average for companies of similar size in United States of America.
Management Team

Colin Goldschmidt

TITLE
CEO, MD & Executive Director
COMPENSATION
A$5M
AGE
65

Chris Wilks

TITLE
Finance Director
COMPENSATION
A$2M
AGE
61
TENURE
26.5 yrs

Philip Dubois

TITLE
Executive Director
COMPENSATION
A$814K
AGE
73

Peter Savage

TITLE
Chief Business Officer

David Byrne

TITLE
Chief Executive Officer of The Doctors Laboratory
COMPENSATION
A$1M
AGE
60

Paul Alexander

TITLE
Deputy CFO & Company Secretary
COMPENSATION
A$354K
AGE
53
TENURE
18.5 yrs

G. Schottdorf

TITLE
Chief Executive Officer of Schottdorf Group
COMPENSATION
A$725K

Prashan Kulasekera

TITLE
Assistant Company Secretary
AGE
47
Board of Directors Tenure

Average tenure and age of the Sonic Healthcare board of directors in years:

11.5
Average Tenure
61.5
Average Age
  • The average tenure for the Sonic Healthcare board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Mark Compton

TITLE
Chairman
COMPENSATION
A$425K
AGE
58
TENURE
3.7 yrs

Colin Goldschmidt

TITLE
CEO, MD & Executive Director
COMPENSATION
A$5M
AGE
65
TENURE
26.5 yrs

Chris Wilks

TITLE
Finance Director
COMPENSATION
A$2M
AGE
61
TENURE
29.6 yrs

Philip Dubois

TITLE
Executive Director
COMPENSATION
A$814K
AGE
73
TENURE
18 yrs

Lou Panaccio

TITLE
Non-Executive Independent Director
COMPENSATION
A$258K
AGE
62
TENURE
14.1 yrs

Kate Spargo

TITLE
Non-Executive Independent Director
COMPENSATION
A$240K
AGE
68
TENURE
9 yrs

Elizabeth Wilson

TITLE
Non-Executive Independent Director
COMPENSATION
A$233K
AGE
60
TENURE
9 yrs

Neville Mitchell

TITLE
Independent Non-Executive Director
COMPENSATION
A$165K
AGE
59
TENURE
1.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
05. Mar 19 Buy Kathryn Spargo Individual 26. Feb 19 26. Feb 19 1,230 $17.05 $20,977
28. Jan 19 Sell BlackRock, Inc. Company 09. Nov 16 24. Jan 19 -9,222,277 $19.09 $-172,604,540
28. Jan 19 Buy BlackRock, Inc. Company 09. Nov 16 25. Jan 19 13,962,197 $19.21 $266,634,990
19. Dec 18 Sell Veritas Asset Management LLP Company 03. Jul 18 11. Dec 18 -963,750 $17.88 $-17,233,631
28. Sep 18 Buy Neville Mitchell Individual 26. Sep 18 26. Sep 18 4,000 $18.31 $73,251
17. Sep 18 Buy Kathryn Spargo Individual 13. Sep 18 13. Sep 18 2,000 $17.92 $35,833
X
Management checks
We assess Sonic Healthcare's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Sonic Healthcare has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SKHC.F News

Simply Wall St News

SKHC.F Company Info

Description

Sonic Healthcare Limited, a healthcare company, provides medical diagnostic services, and administrative services and facilities to medical practitioners. The company operates through Laboratory, Imaging, and Other segments. It offers laboratory medicine/pathology and radiology/diagnostic imaging services to clinicians, hospitals, community health services, and their patients. The company also provides general practice, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, hospital avoidance programs, and clinical trials and chronic disease management programs. In addition, it operates 238 primary care clinics. Sonic Healthcare Limited operates in Australia, the United States, Germany, and internationally. The company was formerly known as Sonic Technology Australia Limited and changed its name to Sonic Healthcare Limited in November 1995. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Details
Name: Sonic Healthcare Limited
SKHC.F
Exchange: OTCPK
Founded:
A$9,131,808,075
473,944,821
Website: http://www.sonichealthcare.com
Address: Sonic Healthcare Limited
Grosvenor Place,
Level 22,
Sydney,
New South Wales, 2000,
Australia
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX SHL Ordinary Shares Australian Securities Exchange AU AUD 02. Jan 1992
OTCPK SKHC.F Ordinary Shares Pink Sheets LLC US USD 02. Jan 1992
DB SAB Ordinary Shares Deutsche Boerse AG DE EUR 02. Jan 1992
CHIA SHL Ordinary Shares Chi-X Australia AU AUD 02. Jan 1992
OTCPK SKHH.Y SPONSORED ADR Pink Sheets LLC US USD 28. Aug 2017
Number of employees
Current staff
Staff numbers
35,000
Sonic Healthcare employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/24 01:49
End of day share price update: 2019/07/23 00:00
Last estimates confirmation: 2019/07/23
Last earnings filing: 2019/02/19
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.